Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elspeth M Beauchamp

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Research Communications|June 28, 2023
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm CellsDiana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti, et al.
Oncotarget|January 7, 2020
Inhibitory effects of SEL201 in acute myeloid leukemiaEwa M Kosciuczuk, Aroop K Kar, Gavin T Blyth, et al.
Cancer Research Communications|November 16, 2022
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progressionMariafausta Fischietti, Frank Eckerdt, Ricardo E Perez, et al.
Blood|December 28, 2018
Identification and targeting of novel CDK9 complexes in acute myeloid leukemiaElspeth M Beauchamp, Sameem M Abedin, Sara G Radecki, et al.
JCI Insight|January 27, 2026
Schlafen 5 is an intracellular immune checkpoint and controls interferon responses in pancreatic ductal adenocarcinomaMariafausta Fischietti, Markella Zannikou, Elspeth M Beauchamp, et al.
Oncogene|April 13, 2021
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinomaMariafausta Fischietti, Frank Eckerdt, Gavin T Blyth, et al.
Nature Communications|April 2, 2022
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasmsDiana Saleiro, Jeremy Q Wen, Ewa M Kosciuczuk, et al.
Molecular Cancer Research : MCR|October 19, 2017
Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA TranslationJonathan B Bell, Frank Eckerdt, Harshil D Dhruv, et al.
Cell Reports|April 21, 2015
Central role of ULK1 in type I interferon signalingDiana Saleiro, Swarna Mehrotra, Barbara Kroczynska, et al.
Molecular Cancer Therapeutics|December 21, 2025
Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignanciesElspeth M Beauchamp, Atul Jain, Matt Clutter, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Research Communications|June 28, 2023
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm CellsDiana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti, et al.
Oncotarget|January 7, 2020
Inhibitory effects of SEL201 in acute myeloid leukemiaEwa M Kosciuczuk, Aroop K Kar, Gavin T Blyth, et al.
Cancer Research Communications|November 16, 2022
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progressionMariafausta Fischietti, Frank Eckerdt, Ricardo E Perez, et al.
Blood|December 28, 2018
Identification and targeting of novel CDK9 complexes in acute myeloid leukemiaElspeth M Beauchamp, Sameem M Abedin, Sara G Radecki, et al.
JCI Insight|January 27, 2026
Schlafen 5 is an intracellular immune checkpoint and controls interferon responses in pancreatic ductal adenocarcinomaMariafausta Fischietti, Markella Zannikou, Elspeth M Beauchamp, et al.
Oncogene|April 13, 2021
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinomaMariafausta Fischietti, Frank Eckerdt, Gavin T Blyth, et al.
Nature Communications|April 2, 2022
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasmsDiana Saleiro, Jeremy Q Wen, Ewa M Kosciuczuk, et al.
Molecular Cancer Research : MCR|October 19, 2017
Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA TranslationJonathan B Bell, Frank Eckerdt, Harshil D Dhruv, et al.
Cell Reports|April 21, 2015
Central role of ULK1 in type I interferon signalingDiana Saleiro, Swarna Mehrotra, Barbara Kroczynska, et al.
Molecular Cancer Therapeutics|December 21, 2025
Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignanciesElspeth M Beauchamp, Atul Jain, Matt Clutter, et al.
Pageof 4